Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barcena Marugan

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|September 10, 2003
Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudineR Barcena Marugan, L Cid Gomez, P Lopez Serrano
Transfusion|October 1, 1989
Serum alanine aminotransferase (ALT) assay and incidence of posttransfusion non-A,non-B hepatitisR Barcena Marugan, C Zamora, A Moreno, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|July 1, 1982
[Ischemic hepatitis following left ventricular insufficiency]R Barcena Marugan, A Domínguez, L Oteo, et al.
Transplantation Proceedings|September 10, 2003
Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograftE Albeniz Arbizu, R Barcena Marugan, E Oton Nieto, et al.
Transplantation Proceedings|January 3, 2006
Variability of MELD score during the year before liver transplantationE Oton-Nieto, R Barcena-Marugan, E Carrera-Alonso, et al.
Transplantation Proceedings|September 10, 2003
Analysis of hepatitis C viral quasispecies in liver transplantationJ Moreno Garcia, S del Campo Terron, G Moraleda Garcia, et al.
Transplantation Proceedings|September 10, 2003
Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary resultsE Albeniz Arbizu, R Barcena Marugan, E Oton Nieto, et al.
Medicina Clinica|March 31, 1984
[Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies]V F Moreira Vicente, M A Simón Marco, J M Pascasio Acevedo, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|September 10, 2003
Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudineR Barcena Marugan, L Cid Gomez, P Lopez Serrano
Transfusion|October 1, 1989
Serum alanine aminotransferase (ALT) assay and incidence of posttransfusion non-A,non-B hepatitisR Barcena Marugan, C Zamora, A Moreno, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|July 1, 1982
[Ischemic hepatitis following left ventricular insufficiency]R Barcena Marugan, A Domínguez, L Oteo, et al.
Transplantation Proceedings|September 10, 2003
Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograftE Albeniz Arbizu, R Barcena Marugan, E Oton Nieto, et al.
Transplantation Proceedings|January 3, 2006
Variability of MELD score during the year before liver transplantationE Oton-Nieto, R Barcena-Marugan, E Carrera-Alonso, et al.
Transplantation Proceedings|September 10, 2003
Analysis of hepatitis C viral quasispecies in liver transplantationJ Moreno Garcia, S del Campo Terron, G Moraleda Garcia, et al.
Transplantation Proceedings|September 10, 2003
Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary resultsE Albeniz Arbizu, R Barcena Marugan, E Oton Nieto, et al.
Medicina Clinica|March 31, 1984
[Antibodies against hepatitis B virus in chronic non-alcoholic HBsAg-negative hepatopathies]V F Moreira Vicente, M A Simón Marco, J M Pascasio Acevedo, et al.
Pageof 1